By Mutuvi Janet
AstraZeneca has awarded a fully funded two-year scholarship to six research finalists from the the R&D Postdoctoral Challenge at one of the company’s strategic R&D centers in Cambridge, UK, Gaithersburg, US or Gothenburg, Sweden.
The winners from Africa, the Middle East and Europe have been awarded fully funded postdoctoral research positions and will be able to access the company’s expertise, compounds, novel tools and technologies, and mentoring support to turn their ideas into reality.
Prof. Sir Mene Pangalos, Executive Vice President, Biopharmaceuticals lauded the six scholarship beneficiaries who were selected among 120 participants.
He added that the Challenge which was launched in March 2022 encouraged early career scientists to submit their own research proposals to accelerate drug discovery for some of the world’s most complex diseases.
“We launched the challenge to promote diversity of thought and stimulate research opportunities across the globe. The final event was successful in bringing together the brightest minds to help them turn their ideas into meaningful benefits for patients and fuel their early career development. I look forward to re-running the programme in future years,” he said.
The R&D Postdoctoral Challenge forms part of AstraZeneca’s commitment to supporting early talent, providing opportunities to work within a diverse and inclusive environment that enables science to thrive.
People are encouraged to participate in this programme in order to create a real impact for patients,society and healthcare systems.
